Endoscopic Band Ligation vs Pharmacological Therapy or Both as Secondary Prophylaxis for Esophageal Variceal Bleeding in Chronic Liver Disease Patients
Abstract
To compare beta blocker, endoscopic variceal band ligation (EVBL) and combination of both for prevention of re-bleeding of esophageal varices in chronic liver disease (CLD) patients.
This was a randomized controlled trial done at North Medical ward, Mayo hospital, Lahore for 6 months. After ethical approval, 320 patients of ages 18-80 years with either gender admitted with variceal bleed were included in study. After stabilizing with standard treatment of EVBL & beta blocker, patients were randomly divided in four groups, i.e. group I was put on propranolol, group II had EVBL every 2 weekly, group III had EVBL every 4 weekly and group IV had combination of 2 weekly EVBL with beta blocker. All patients were followed for six months. Quantitative variables in four groups were compared by ANOVA test whereas qualitative variables by chi-square test.
After 6 months follow up re-bleeding was noted in 10 patients after one month (8 in group I, 2 in group II while no patient rebleed in group III and group IV). 61 (19.06%) patients rebleed after 3 months (40/7/14/0). 107 (33.43%) patients rebleed after 6 months (73/16/18/0 respectively). Significantly more re-bleeding occurred in group I patients whereas no rebleed occurred in group IV patients. No significant difference was noted in group II and III. Overall 7 patients lost the follow up.
Combination of beta blocker with EVBL is more effective than EVBL and beta blocker alone in secondary prophylaxis of variceal bleeding in CLD patients.
How to Cite This Article
Farooq M, Niaz Z, Mumtaz SU, Khan AA, Iqtadar S, Abaidullah S. Endoscopic Band Ligation vs Pharmacological Therapy or Both as Secondary Prophylaxis for Esophageal Variceal Bleeding in Chronic Liver Disease Patients. J Pak Soc Intern Med. 2021;2(3):205–208. doi:10.70302/jpsim.v2i3.2147
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- Asrani SK, Devarbhavi H,Eaton J,Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151-171.
- Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterol. 2001;120(3): 726-48.
- Reiberger T, Bucsics T, Paternostro R, Pfisterer N, Riedl F, Mandorfer M. Small Esophageal Varices in Patients with Cirrhosis-Should We Treat Them?. Curr Hepatol Rep. 2018;17(4):301-15.
- Garcia-Tsao G, Friedman S, Iredale J, Pinzani M, Hepatology. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. 2010;51(4):1445-9.
- Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol. 2009;6(10):573-82.
- Elsebaey MA, Tawfik MA, Ezzat S, Selim A, Elashry H, Abd-Elsalam S. Endoscopic injection sclerotherapy versus N-Butyl-2 Cyanoacrylate injection in the management of actively bleeding esophageal varices: a randomized controlled trial. BMC Gastroenterol. 2019;https://doi.org/10.1186/s12876-019-0940-1. doi:10.1186/s12876-019-0940-1
- Wang J, Chen S, Naga YM, Liu J, Dai M, Yang S, Wang L, Ye B. Esophageal Variceal Ligation Monotherapy versus Combined Ligation and Sclerotherapy for the Treatment of Esophageal Varices. Canadian J Gastroenterol Hepatol. 2021;ID 8856048.
- Rodrigues SG, Mendoza YP, Bosch J. Beta-blockers in cirrhosis: Evidence-based indications and limitations. JHEP Rep. 2019;2(1):100063.
- Gluud LL, Langholz E, Krag A. Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices. Aliment Pharmacol Ther. 2010; 32(7): 859-71.
- Reiberger T, Ferlitsch A, Payer BA, Mandorfer M, Heinisch BB, Hayden H, et al. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. J Hepatol. 2013; 58(5): 911– 21.
- Ezechi O, Gab-Okafor CV, Ostergeren PO, Pettersson KO. Willingness and acceptability of cervical cancer screening among HIV positive Nigrian women. BMC Public Health. 2013;13(1):1-8.
- Sarwar S, Azeem M, Ayub M et al. Optimum Therapy for Secondary Prophylaxis of Variceal Bleeding Patient: Endoscopic, Pharmacological or Combination, A Randomized Study, Annals KEMU. 2010; 16(1): 69-72.
- Funakoshi N, Duny Y, Valats JC, Ségalas-Largey F, Flori N, Bismuth M, Daurès JP, Blanc P. Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding. Ann Hepatol. 2012;11(3):369-83.
- Lo GH, Chen WC, Chan HH, Tsai WL, Hsu PI, Lin CK, Chen TA, Lai KH. A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding. J Gastroenterol Hepatol. 2009;24(6):982-7.
- Thiele M, Krag A, Rohde U, Gluud LL. Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices, Alimentary Pharmacology & Therapeutics. 2012;35(10):1155-65.
- Cheung J, Zeman M, van Zanten SV, Tandon P. Systematic review: secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from oesophageal varices. Aliment Pharmacol Ther. 2009;30(6):577-88.
- Kumar A, Jha SK, Sharma P, Dubey S, Tyagi P, Sharma BC, Sarin SK. Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence. Gastroenterology. 2009;137(3):892-901.
- Guadalupe Garcia-Tsao, Juan G. Abraldes, Annalisa Berzigotti, Jaime Bosch, Portal Hypertensive Bleeding in Cirrhosis: Risk Stratification, Diagnosis, and Management: 2016 Practice Guidance by the American Association for the Study of Liver Diseases Hepatology 2017;65(1):310-335.
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.